Home Blog Page 711

Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study

  • High Impact Session presented at Heart Rhythm Society’s Congress in Chicago
  • First time showing results of new Less Invasive approach
  • Improvement in Left Ventricular Ejection Fraction (LVEF), 6 Minute Walk Test (6MWT), Quality of Life (QOL) and New York Heart Association (NYHA) class.

CHICAGO, April 25, 2026 /PRNewswire/ — Berlin Heals Holding AG, a clinical-stage medical device company focused on transforming the treatment of heart failure (HF) with a first-in-class, durable therapy, announced the presentation of positive results from the First-In-Human (FIH) CMIC-III study.  The study evaluated the safety of a novel, less invasive approach to implanting the cardiac microcurrent (CMIC) device. The data were presented by Dr. Marat Fudim, Associate Professor of Cardiology and HF at Duke University, during a High Impact Science Session at the Heart Rhythm Society’s Annual Congress in Chicago, Illinois.

This marks the first-time the CMIC system has been implanted via an outpatient procedure. The results demonstrated clinically significant improvements in LVEF, 6MWT, QOL and NYHA with a strong safety profile. Notably, these results are consistent with the robust outcomes previously observed in studies using the pericardial surgical implantation approach. To date, a total of 52 patients have been implanted across 3 studies.

“Earlier heart failure studies of microcurrent therapy demonstrated compelling clinical benefits but required a surgical implantation approach.” Said Sr. Author of the study Professor William T. Abraham, M.D., College of Medicine Distinguished Professor at The Ohio State University Wexner Medical Center. “These new data from the CMIC-III study show that we can achieve comparable improvements using a less invasive, outpatient procedure, significantly enhancing the safety profile and expanding access to a much broader population of patients.”

Berlin Heals has initiated Phase II of the CMIC-III less invasive FIH study. This next phase will evaluate the therapy in patients with mildly reduced left ventricular ejection fraction (LVEF >40% and <50%) expanding the clinical experience into a broader heart failure population. In parallel the company will launch the C-MIC-IV double blind sham- controlled trial, enrolling patients with both non-ischemic and ischemic heart failure and LVEF of 20-40%, primarily across Western European centers.

Together, these two studies are expected to increase the total number of implanted patients to approximately 122, generating critical data to inform the design and significantly de-risk the FDA IDE pivotal trial for market approval.

Berlin Heals Holding AG is a Swiss joint-stock company founded in 2014. The company’s C-MIC technology delivers a constant electrical microcurrent to the heart, generating a localized electrical field designed to improve cardiac function. Based on clinical studies to date, this approach has shown the potential to deliver rapid and sustained benefits for patients suffering from heart failure.

Youlife Group Inc. Reschedules FY2025 Earnings Conference Call to April 28 at 9 AM ET

SHANGHAI, April 25, 2026 /PRNewswire/ — Youlife Group Inc. (“Youlife” or the “Company”) (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that the Company has rescheduled its full year 2025 earnings conference call to take place on Tuesday, April 28th, 2026, at 9 AM ET.

Earnings Call Details
Date: Tuesday, April 28, 2026
Time: 9:00 AM ET

Participant Listening Options
Interested participants can join the event by using the dial-in numbers, or by clicking the link to join, provided below, for instant access to the call.

U.S. Domestic: 1-800-717-1738
International: 1-646-307-1865
Link to Join: https://emportal.ink/3O4BpMI

Event Replay Options
A replay of Youlife Group’s earnings conference call will also be made available 3 hours following the conclusion of the call, accessible until Tuesday, May 12, 2026, at 11:59 PM ET. For anyone unable to attend the live event that would like to access the event replay, please dial the numbers and provide the access ID outlined below.

Replay Dial-In: 1-844-512-2921 or 1-412-317-6671
Access ID: 11161721

About Youlife Group Inc.

Youlife is a leading global provider of blue-collar lifecycle services, dedicated to modernizing blue-collar employment through data, training, and AI-driven workforce solutions. In the talent services sector, Youlife operates 180 domestic branches and over 10 overseas offices. By partnering with more than 10,000 renowned enterprises worldwide, Youlife provides stable and future-ready workforce infrastructure at scale. Under its “School-Enterprise Cooperation” model, Youlife maintains a nationwide network of vocational schools, including 25 schools and 25 curriculum development programs, covering 37 cities and counties across 16 provinces in China. For more information, please visit: https://ir.youlife.cn/.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements also include, but are not limited to, statements regarding future events and the future results of Youlife current expectations, estimates, forecasts, and projections about the industry in which Youlife operates, as well as the beliefs and assumptions of Youlife’s management. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Youlife’s management and are not predictions of actual performance. These statements involve risks, uncertainties and other factors that may cause Youlife’s actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by these forward-looking statements.

 

MALAYSIA HEALTHCARE RETURNS TO MEDAN AS INDONESIAN PATIENTS SEEK TRUSTED SECOND OPINIONS ABROAD

MEDAN, Indonesia, April 25, 2026 /PRNewswire/ — Malaysia has steadily emerged as one of the most trusted destinations for Indonesian patients seeking timely and reliable care. Following its last major outreach in 2022, Malaysia Healthcare returns to Medan this year, reconnecting with a community that has long viewed Malaysian hospitals as a gold standard for second medical opinions and complex treatments. Malaysian hospitals are widely recognised for their internationally accredited facilities, specialised medical expertise and patient-centred care, supported by competitive treatment costs and culturally familiar healthcare services.

This long-standing patient movement has gradually formed a strong Medan–Penang healthcare corridor, connecting residents of North Sumatra with Malaysia’s major hospital hubs. The region serves a population catchment of more than 15 million people, with Medan acting as the primary gateway for patients travelling from surrounding areas such as Aceh, Padang, Pekanbaru, and Binjai to seek treatment abroad. The proximity between the two destinations further strengthens this relationship. Located just 160 kilometres across the Straits of Malacca, Penang can be reached from Medan in about a 40-45 minute flight, with approximately 56 weekly flights connecting Medan to Malaysia’s major hospital hubs. This accessibility has made Malaysian hospitals among the most convenient international healthcare options for residents of western Indonesia. The strong demand from Indonesian patients has also played a major role in shaping Malaysia’s healthcare travel ecosystem. Indonesian healthcare travellers contribute significantly to Malaysia’s medical tourism industry, accounting for approximately 65 per cent of the country’s total medical tourism revenue.

Recognising the importance of this long-standing healthcare connection, the Malaysia Healthcare Travel Council continues to strengthen engagement with the Medan market through the national Malaysia Healthcare brand. Guided by the Healing Meets Hospitality positioning and supported by the Malaysia Year of Medical Tourism 2026, Malaysia Healthcare aims to deepen regional healthcare collaboration while improving patient access to trusted treatment options across Southeast Asia.

As part of these efforts, Malaysia Healthcare brings together a delegation of leading Malaysian hospitals to Medan through MHX Medan 2026, including Island Hospital Penang, winner of Malaysia’s Flagship Medical Tourism Hospital award, as well as Institut Jantung Negara (IJN), Mahkota Medical Centre and Subang Jaya Medical Centre, which were recipients of multiple accolades under the same award, alongside Alpha IVF & Women’s Specialists, GenPrime Everlink Fertility Centre, Gleneagles Hospital Kuala Lumpur, Gleneagles Hospital Penang, Hospital Picaso, Damansara Specialist Hospital 2, Johor Specialist Hospital, MSU Medical Centre, Northern Heart Hospital Penang, Optimax Eye Specialist Centre, Penang Adventist Hospital, Prince Court Medical Centre, Sunway Medical Centre Sunway City Kuala Lumpur, Sunway Medical Centre Penang and Thomson Hospital Kota Damansara. Visitors will have the opportunity to meet specialists directly, explore treatment options and obtain trusted second medical opinions in key areas frequently sought by Indonesian patients, including cardiology, oncology, orthopaedics, fertility treatment and comprehensive health screening.

MHX Medan 2026 aims to surpass the benchmark set during MHX Medan 2022, which generated 1,514 patient enquiries, with a new target of achieving at least 1,665 healthcare leads from the Medan market. The event is expected to attract families seeking clarity on complex diagnoses, patients considering overseas treatment just a short flight away, as well as healthcare facilitators and industry partners interested in strengthening Malaysia–Indonesia healthcare collaboration.

ENDS

For media inquiries and further information, please contact:

Mohamad Shahizam Fauzi
Head, Communications
+603 8776 6168
shahizam.f@mhtc.org.my

Muhammad Rasydan Ma’at
Asst. Manager, Communications
+603 8776 6168
rasydan.m@mhtc.org.my

About Malaysia Healthcare Travel Council

Malaysia Healthcare Travel Council (MHTC), established in 2009 under the purview of the Ministry of Health (MOH) Malaysia, is entrusted with developing and nurturing the “Malaysia Healthcare” brand. MHTC enhances, coordinates, and promotes Malaysia’s healthcare travel industry by fostering industry collaborations and building valuable public-private partnerships both domestically and internationally. With 80 member hospitals nationwide, MHTC continues to elevate the healthcare travel ecosystem through strong branding, seamless patient experiences, and strategic market initiatives. In line with these efforts, MHTC is spearheading the Malaysia Year of Medical Tourism (MYMT) 2026, the nation’s first dedicated year to celebrate and advance healthcare travel. MYMT 2026 serves as a milestone initiative to showcase Malaysia’s world-class healthcare offerings, strengthen its position as the premier global healthcare destination, and highlight the industry’s significant contribution to the national economy.

More information can be found at https://www.malaysiahealthcare.org

Hindustan Zinc clocks record Q4 net profit of US$ 550 million, up 68% YoY; EBITDA at US$ 847 million, driven by efficiency-led growth

UDAIPUR, India, April 25, 2026 /PRNewswire/ — India-based Hindustan Zinc Limited, a Vedanta Group company and the world’s largest integrated zinc producer, announced its financial results for the fourth quarter and year ended 31st March 2026.

For the full year, the company reported its highest-ever revenue of US$ 4,623 million, up 20% YoY, and all-time high EBITDA of US$ 2,508 million, up 27% YoY, with an industry-leading EBITDA margin of 54%. Net profit for the year stood at a record US$ 1,565 million, up 34% YoY. In the fourth quarter, EBITDA stood at record US$ 847 million, up 61% YoY, while net profit rose to a record US$ 550 million, up 68% YoY.

Operationally, the company achieved its highest-ever mined metal production of 1,114 Kt and second-best refined metal production of 1,048 Kt. During the year, it successfully debottlenecked its Chanderiya and Dariba smelters in Rajasthan, increasing its refined zinc capacity. 

Commenting on Hindustan Zinc’s performance, Arun Misra, Chief Executive Officer, said:

“We are proud to deliver a record-breaking performance this quarter and for the full year, by crossing 1.1 million tonnes of mined metal production. We also delivered a record quarterly refined metal production at the lowest cost of production excluding royalty of $ 959 per tonne despite the ongoing geopolitical challenges. These milestones reflect the resilience of our business, strong execution, and unwavering focus on value creation. As we step into our 2.0 growth phase, we are strengthening our strategic roadmap. With our move into critical minerals, we are aligning with future-facing sectors while contributing meaningfully to India’s growth and long-term stakeholder value.”

Silver continued to be a significant value driver, with annual production of 627 tonnes, contributing 45% to overall profitability. In the fourth quarter, silver production stood at 176 tonnes, up 11% QoQ.

About Hindustan Zinc

Hindustan Zinc Limited is the world’s largest integrated zinc producer. The company has been recognized as the world’s most sustainable metals & mining company by the S&P Global CSA 2025 for the third consecutive year and the first Indian company to become an ICMM member.

Note:
Quarterly zinc cost of production is the lowest since underground transition
USD-INR rate is 91.50 for the quarter and 88.36 for the full year

Stéphane Rolland Transforms Barcelona Bridal Night into a Celebration of Love

BARCELONA, Spain, April 25, 2026 /PRNewswire/ — French couturier Stéphane Rolland made his Spanish runway debut on Wednesday night at the tenth edition of Barcelona Bridal Night, transforming the gala into a multidisciplinary spectacle of fashion, music, art and poetry. The presentation, held during Barcelona Bridal Fashion Week 2026 (BBFW), marked a milestone for the event and showcased the couturier’s vision of bridal fashion as an emotional and artistic expression.

Designer Stéphane Rolland and models Nieves Álvarez and Ariadna Gutiérrez during the Barcelona Bridal Night runway show.
Designer Stéphane Rolland and models Nieves Álvarez and Ariadna Gutiérrez during the Barcelona Bridal Night runway show.

Under the title Love for Peace, Rolland and his partner Pierre Martinez, serving as artistic director, devised a visual and musical ceremony at Hall 8 of Fira de Barcelona’s Montjuïc venue. Lighting, sound and spatial design drove an optimistic narrative that framed fashion as a universal language and a symbol of peace and hope.

The evening began with a runway show featuring 23 designs created by students from fashion schools IED Barcelona, LCI Barcelona, and ESDI and developed under the direct mentorship of Stéphane Rolland as part of the Sculpted by Nature project. The pieces, crafted from fabrics provided by Gratacós explored the relationship between nature, volume, and organic forms through sculptural silhouettes, precise structures, and meticulous attention to detail, highlighting the passing on of expertise and the intergenerational dialogue that marked the start of the gala.

Rolland then presented 80 looks, including his ready-to-wear bridal line, Noce de Sang, and a selection of signature couture gowns. Nieves Álvarez, a frequent muse of the French master, walked the runway alongside Latin-American top-model Ariadna Gutiérrez, and models as Laura Sánchez, Davinia Pelegrí, Marta Ortiz and Mercedes Muñoz.

The live music was provided by the Barcelona Youth Symphony Orchestra (JOSB), conducted by Carlos Checa and comprising 65 musicians, who accompanied the show with an eclectic and emotional repertoire including works by Chopin, Debussy, Bach or Vivaldi. Actress Nathalie Poza recited Jacques Prévert’s “Cet amour” and excerpts from classic love songs between sequences.

Ahead of BBFW, Rolland donated 22 original sketches now displayed at Barcelona Bridal Night museum installation to raise funds for the Kálida Foundation, which supports people undergoing cancer treatment and their families. The gala concluded with a tenth-anniversary celebration, featuring a commemorative cake created by Lolita Bakery, reinforcing the event’s status as a key international platform in bridal fashion.

/C O R R E C T I O N — Flexsys/

In the news release, FLEXSYS TO INCREASE PRICES FOR INSOLUBLE SULFUR IN INDIA, issued 22-Apr-2026 by Flexsys over PR Newswire, we are advised by the company that the original version contained incorrect information introduced by PR Newswire during transmission. The complete, corrected release follows, with additional details at the end:

FLEXSYS TO INCREASE PRICES FOR INSOLUBLE SULFUR IN INDIA

AKRON, Ohio, April 22, 2026 /PRNewswire/ — Effective for all shipments on or after May 1, 2026, Flexsys announced it will increase prices for all Insoluble Sulfur grades and package types sold in India by USD $0.75/kg.

This price increase reflects the continued escalation of oil‑derived raw materials, energy, and logistics costs, driven by significant disruptions to Middle East export flows through the Strait of Hormuz.

About Flexsys
Flexsys is a global specialty chemicals and materials technology company that innovates and produces a range of tire additives with the purpose of enabling tire companies to improve tire performance and manufacturing productivity, while enhancing sustainability through innovation. Based in Akron, Ohio, with manufacturing facilities across North America, South America, Europe and Asia, our global team is committed to the success of our customers.

For additional information about Flexsys, please visit www.flexsys.com

Correction: An earlier version of this release was updated to remove the section after the website. 

NYSE Content Update: AI Company Vast Data Announces $30 Billion Valuation

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, April 24, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.

 

Contango Silver & Gold Execs to join NYSE Live.

Ashley Mastronardi delivers the pre-market update on April 24th

  • Equities are up Friday morning after President Trump announced a three-week ceasefire between Israel and Lebanon.
  • Shares of NYSX component Texas Instruments rose by 19% Thursday following earnings and an analyst upgrade, clinching its best day since 2000.
  • Vast Data’s Founder and CEO Renen Hallak will join NYSE Live to discuss the company’s $1 billion Series F, with Nvidia among participants.
  • Contango Silver & Gold (NYSE American: CTGO) executives will join NYSE Live after the Opening Bell to reveal what’s next following its recent merger.

Opening Bell
Contango Silver & Gold (NYSE American: CTGO) celebrates its recent merger

Closing Bell
Sealed Air Corp. (NYSE: SEE) celebrates its next chapter of growth

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

Neuberger Berman ETF at the NYSE on April 23rd
Neuberger Berman ETF at the NYSE on April 23rd

 

 

 

AI Transforms the World: XPENG Showcases Its Full-Stack Physical AI Ecosystem at Auto China 2026

BEIJING, April 24, 2026 /PRNewswire/ — The 19th Beijing International Automotive Exhibition (Auto China 2026) officially opened today, where XPENG made a strong impression with its comprehensive product lineup. The showcase featured several major new models, including the GX, the MONA M03, the next P7, and the X9. In addition to its vehicle portfolio, XPENG showcased its next-generation humanoid robot, IRON, and its flying car “Land Aircraft Carrier”. Together, these innovations demonstrate the company’s latest advancements and its integrated ecosystem strategy in Physical AI.

XPENG Beijing Autoshow press kit

During the exhibition, around 200 media representatives from Europe, Asia-Pacific, the Americas, the Middle East, and Africa attended XPENG’s Physical AI “Immersive” China Tour. Delegates toured XPENG’s intelligent manufacturing facilities and ARIDGE’s production base, and experienced VLA 2.0 through hands-on test drives. A series of technical seminars provided deeper insight into XPENG’s developments in intelligent driving, design, flying vehicles, robotics, powertrain systems, and ultra-fast charging technologies.

XPENG’s First VLA 2.0 Intelligent Driving Report Released; Campus and Underground Parking Lot Safari Are Coming Soon

In March 2026, XPENG officially rolled out its VLA 2.0 intelligent driving system. At Auto China 2026, the company released its first VLA 2.0 Intelligent Driving Report, offering a comprehensive analysis of the system’s performance across key metrics, including user adoption, engagement, and purchasing influence. The report indicates that VLA 2.0 is playing an increasingly pivotal role in consumer decision-making. Orders for the XPENG Ultra series rose by 118% month-over-month, with advanced intelligent driving capabilities becoming a primary driver of conversions.

Since the launch of in-store VLA 2.0 demonstrations, nearly 100,000 consumers have participated, achieving a 98% satisfaction rate. Notably, the average time from test drive to order placement has decreased by 44.7%, signaling a shift in intelligent driving from a value-added feature to a core purchase consideration. Usage data further demonstrates strong user engagement. During the first week of ownership, 98.52% of users activated intelligent driving features daily. These results suggest that VLA 2.0 effectively addresses long-standing industry challenges related to usability and adoption, delivering a more intuitive and reliable driving experience.

XPENG also announced continued expansion of full-scenario capabilities. New features — Campus and Underground Parking Safari—are scheduled for release soon. These functions are designed to handle complex edge cases, including low-light conditions, adverse weather, absence of navigation data, and unmarked roads, further enhancing end-to-end intelligent mobility.

He Xiaopeng, Chairman and CEO of XPENG, said: “After 12 years, we are entering a new phase. From smart EVs to flying cars, Turing AI chips, large models, humanoid robots, and Robotaxi, we are steadily turning our vision into reality through Physical AI. It is on this integrated technological foundation that we are driving forward the future of mobility. The real value of intelligent driving lies not just in capability, but in delivering greater efficiency and a more relaxing experience.”

Advancing Physical AI: A Blueprint for Future Mobility

At the conference, He Xiaopeng introduced the GX, a vehicle designed for the L4 autonomous driving era. Positioned as China’s first fully in-house developed, factory-integrated Robotaxi prototype intended for mass production, the GX represents a significant milestone. It is equipped with up to four Turing chips, delivering 3,000 TOPS of computing power, and is powered by the VLA 2.0 system. Built on an architecture purpose-designed for L4 autonomy, the GX sets a new benchmark in intelligent driving capability.

In 2025, XPENG’s overseas deliveries surpassed 45,000 units, representing a 96% year-on-year increase, ranking No.1 in overseas pure-electric sales among Chinese NEV startups. Looking ahead, XPENG will continue to deepen its investment in Physical AI technologies while accelerating the commercialization of next-generation products such as the flying car and humanoid robotics. By optimizing user mobility and life experiences through pragmatic technological innovation, XPENG aims to bring efficiency and convenience to a world powered by Physical AI.

About XPENG

Founded in 2014, XPENG is a leading AI-driven mobility company that designs, develops, manufactures, and markets Smart EVs, catering to a growing base of tech-savvy consumers. With the rapid advancement of AI, XPENG aspires to become a global leader in AI mobility, with a mission to drive the Smart EV revolution through cutting-edge technology, shaping the future of mobility. To enhance the customer experience, XPENG develops its full-stack advanced driver-assistance system (ADAS) technology and intelligent in-car operating system in-house, along with core vehicle systems such as the powertrain and electrical/electronic architecture (EEA). Headquartered in Guangzhou, China, XPENG also operates key offices in Beijing, Shanghai, Silicon Valley, and Amsterdam. Its Smart EVs are primarily manufactured at its facilities in Zhaoqing and Guangzhou, Guangdong province. XPENG is listed at the New York Stock Exchange (NYSE: XPEV) and Hong Kong Exchange (HKEX: 9868).

Contacts:

XPENG PR Department
Email: pr@xiaopeng.com
Website: https://www.xpeng.com/